Artwork

Content provided by CorConsult Rx, Mike Corvino, BCPS, BCACP, CDCES, and Cole Swanson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CorConsult Rx, Mike Corvino, BCPS, BCACP, CDCES, and Cole Swanson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

SGLT-2 Inhibitors in Renal Disease and UTI Review

50:38
 
Share
 

Manage episode 241263072 series 1947483
Content provided by CorConsult Rx, Mike Corvino, BCPS, BCACP, CDCES, and Cole Swanson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CorConsult Rx, Mike Corvino, BCPS, BCACP, CDCES, and Cole Swanson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

On this episode, we are joined by two MUSC 4th year pharmacy students, Ian and Allison. We discuss the CREDENCE trial (NEJM 2019) that showed the benefit of canagliflozin for renal protection in patients with diabetes. We also review the pathophysiology, diagnosis, and treatment of urinary tract infections.

If you have any questions, reach out to us on any of the following:

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

  continue reading

273 episodes

Artwork
iconShare
 
Manage episode 241263072 series 1947483
Content provided by CorConsult Rx, Mike Corvino, BCPS, BCACP, CDCES, and Cole Swanson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CorConsult Rx, Mike Corvino, BCPS, BCACP, CDCES, and Cole Swanson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

On this episode, we are joined by two MUSC 4th year pharmacy students, Ian and Allison. We discuss the CREDENCE trial (NEJM 2019) that showed the benefit of canagliflozin for renal protection in patients with diabetes. We also review the pathophysiology, diagnosis, and treatment of urinary tract infections.

If you have any questions, reach out to us on any of the following:

Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Instagram and other social media platforms - @corconsultrx

This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

  continue reading

273 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide